论文部分内容阅读
急性心肌梗塞(ＡＭＩ)早期静脉溶栓治疗因其方便、易行、有效的特点已被临床广泛接受[1]。为探讨尿激酶(ＵＫ)对ＡＭＩ急性期预后的影响及安全性,我们自1996年12月～1998年11月对82例ＡＭＩ患者进行了静脉溶栓和常规药物治疗的临床观察,现将观察结果报告如下。1 临床资料11
Early intravenous thrombolytic therapy for acute myocardial infarction (AMI) has been clinically widely accepted due to its convenient, easy and effective [1]. To investigate the effect and safety of urokinase (UK) on the acute phase prognosis of AMI, 82 patients with AMI who underwent intravenous thrombolysis and conventional medical therapy from December 1996 to November 1998 were observed. The results are reported below. 1 clinical data 11